Literature DB >> 24045577

Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells.

J L Bishop1, M E Roberts1, J L Beer1, M Huang1, M K Chehal1, X Fan1, L A Fouser2, H L Ma2, J T Bacani3, K W Harder1.   

Abstract

Intestinal homeostasis requires a complex balance of interactions between diverse resident microbial communities, the intestinal epithelium, and the underlying immune system. We show that the Lyn tyrosine kinase, a critical regulator of immune cell function and pattern-recognition receptor (PRR) responses, has a key role in controlling gastrointestinal inflammation. Lyn⁻/⁻ mice were highly susceptible to dextran sulfate sodium (DSS)-induced colitis, whereas Lyn gain-of-function (Lyn(up)) mice exhibited attenuated colitis during acute and chronic models of disease. Lyn(up) mice were hypersensitive to lipopolysaccharide (LPS), driving enhanced production of cytokines and factors associated with intestinal barrier function, including interleukin (IL)-22. Oral administration of LPS was sufficient to protect antibiotic-treated Lyn(up) but not wild-type mice from DSS, highlighting how Lyn-dependent changes in the nature/magnitude of PRR responses can impact intestinal health. Furthermore, protection from DSS-induced colitis and increased IL-22 production in response to LPS did not depend on the adaptive immune system, with increased innate lymphoid cell-derived IL-22 correlating with Lyn activity in dendritic cells. These data reveal a key role for Lyn in the regulation of innate immune responses and control of intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24045577     DOI: 10.1038/mi.2013.60

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  48 in total

1.  Lyn-dependent signaling regulates the innate immune response by controlling dendritic cell activation of NK cells.

Authors:  Danielle L Krebs; Manreet K Chehal; Alexander Sio; Nicholas D Huntington; Mei Lin Da; Pascal Ziltener; Melissa Inglese; Nicole Kountouri; John J Priatel; Jessica Jones; David M Tarlinton; Gary P Anderson; Margaret L Hibbs; Kenneth W Harder
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

Review 2.  Effector and regulatory events during natural killer-dendritic cell interactions.

Authors:  Lorenzo Moretta; Guido Ferlazzo; Cristina Bottino; Massimo Vitale; Daniela Pende; Maria Cristina Mingari; Alessandro Moretta
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

3.  TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.

Authors:  Trine Olsen; Renathe Rismo; Guanglin Cui; Rasmus Goll; Ingrid Christiansen; Jon Florholmen
Journal:  Cytokine       Date:  2011-09-25       Impact factor: 3.861

4.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

5.  IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality.

Authors:  Laure Dumoutier; Magali de Heusch; Ciriana Orabona; Naoko Satoh-Takayama; Gerard Eberl; Jean-Claude Sirard; James P Di Santo; Jean-Christophe Renauld
Journal:  Eur J Immunol       Date:  2011-03-14       Impact factor: 5.532

Review 6.  Recent advances in IL-22 biology.

Authors:  Lauren A Zenewicz; Richard A Flavell
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

7.  Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

Authors:  Tetsuro Takayama; Nobuhiko Kamada; Hiroshi Chinen; Susumu Okamoto; Mina T Kitazume; Jonathan Chang; Yumi Matuzaki; Sadafumi Suzuki; Akira Sugita; Kazutaka Koganei; Tadakazu Hisamatsu; Takanori Kanai; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2010-06-01       Impact factor: 22.682

Review 8.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

9.  Deletion of TLR5 results in spontaneous colitis in mice.

Authors:  Matam Vijay-Kumar; Catherine J Sanders; Rebekah T Taylor; Amrita Kumar; Jesse D Aitken; Shanthi V Sitaraman; Andrew S Neish; Satoshi Uematsu; Shizuo Akira; Ifor R Williams; Andrew T Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

View more
  15 in total

Review 1.  Role of interleukin-22 in inflammatory bowel disease.

Authors:  Lin-Jing Li; Chen Gong; Mei-Hua Zhao; Bai-Sui Feng
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 2.  Cytokines in inflammatory bowel disease.

Authors:  Markus F Neurath
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

Review 3.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

4.  Protein kinase p38α signaling in dendritic cells regulates colon inflammation and tumorigenesis.

Authors:  Tingting Zheng; Baohua Zhang; Ce Chen; Jingyu Ma; Deyun Meng; Jian Huang; Ran Hu; Xinguang Liu; Kinya Otsu; Andrew C Liu; Huabin Li; Zhinan Yin; Gonghua Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-12       Impact factor: 11.205

5.  CARD9 mediates dendritic cell-induced development of Lyn deficiency-associated autoimmune and inflammatory diseases.

Authors:  Jun Ma; Clare L Abram; Yongmei Hu; Clifford A Lowell
Journal:  Sci Signal       Date:  2019-10-08       Impact factor: 8.192

6.  LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism.

Authors:  Raki Sudan; Sandra Fernandes; Neetu Srivastava; Chiara Pedicone; Shea T Meyer; John D Chisholm; Robert W Engelman; William G Kerr
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

7.  IL-22-induced cell extrusion and IL-18-induced cell death prevent and cure rotavirus infection.

Authors:  Zhan Zhang; Jun Zou; Zhenda Shi; Benyue Zhang; Lucie Etienne-Mesmin; Yanling Wang; Xuyan Shi; Feng Shao; Benoit Chassaing; Andrew T Gewirtz
Journal:  Sci Immunol       Date:  2020-10-02

8.  CD45 regulates GM-CSF, retinoic acid and T-cell homing in intestinal inflammation.

Authors:  A Samarakoon; Y A Shim; M Dosanjh; M Crickmer; C Labonté-Raymond; A A Arif; P Johnson
Journal:  Mucosal Immunol       Date:  2016-03-23       Impact factor: 7.313

9.  Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats.

Authors:  Li-Xuan Sang; Bing Chang; Cong Dai; Nan Gao; Wei-Xin Liu; Min Jiang
Journal:  Int J Mol Sci       Date:  2013-12-19       Impact factor: 5.923

Review 10.  STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?

Authors:  Paul M Nguyen; Tracy L Putoczki; Matthias Ernst
Journal:  J Interferon Cytokine Res       Date:  2015-03-11       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.